In vitro and in vivo evidence discourages routine testing and reporting of piperacillin/tazobactam susceptibility of Elizabethkingia species
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:79 |
|---|---|
| Enthalten in: |
The Journal of antimicrobial chemotherapy - 79(2024), 1 vom: 03. Jan., Seite 200-202 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tan, Mei-Chen [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
157044-21-8 |
|---|
| Anmerkungen: |
Date Completed 04.01.2024 Date Revised 04.01.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/jac/dkad322 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM363431853 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM363431853 | ||
| 003 | DE-627 | ||
| 005 | 20240108141640.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/jac/dkad322 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1248.xml |
| 035 | |a (DE-627)NLM363431853 | ||
| 035 | |a (NLM)37850648 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tan, Mei-Chen |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a In vitro and in vivo evidence discourages routine testing and reporting of piperacillin/tazobactam susceptibility of Elizabethkingia species |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.01.2024 | ||
| 500 | |a Date Revised 04.01.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Piperacillin, Tazobactam Drug Combination |2 NLM | |
| 650 | 7 | |a 157044-21-8 |2 NLM | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 650 | 7 | |a Piperacillin |2 NLM | |
| 650 | 7 | |a X00B0D5O0E |2 NLM | |
| 650 | 7 | |a Penicillanic Acid |2 NLM | |
| 650 | 7 | |a 87-53-6 |2 NLM | |
| 650 | 7 | |a beta-Lactamase Inhibitors |2 NLM | |
| 700 | 1 | |a Huang, Ying-Chi |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Pei-Jing |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Wei-Cheng |e verfasserin |4 aut | |
| 700 | 1 | |a Hsu, Shu-Yuan |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Hui-Ying |e verfasserin |4 aut | |
| 700 | 1 | |a Liou, Ci-Hong |e verfasserin |4 aut | |
| 700 | 1 | |a Sun, Jun-Ren |e verfasserin |4 aut | |
| 700 | 1 | |a Lauderdale, Tsai-Ling Yang |e verfasserin |4 aut | |
| 700 | 1 | |a Kuo, Shu-Chen |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of antimicrobial chemotherapy |d 1981 |g 79(2024), 1 vom: 03. Jan., Seite 200-202 |w (DE-627)NLM000017701 |x 1460-2091 |7 nnns |
| 773 | 1 | 8 | |g volume:79 |g year:2024 |g number:1 |g day:03 |g month:01 |g pages:200-202 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/jac/dkad322 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 79 |j 2024 |e 1 |b 03 |c 01 |h 200-202 | ||